3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
4
Myeloproliferative Disorders
3
Thymic aplasia
1
Thrombosis
1
Smoking
1
Sarcoma
1
Primary Dysautonomias
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Metabolic Syndrome
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Insulin Resistance
1
Immunologic Deficiency Syndromes
1
Hyperandrogenism
1
Histiocytoma, Malignant Fibrous
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
imetelstat
1
Vorinostat
1
Spectroscopy, Near-Infrared
1
Phlebotomy
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Hydroxyurea
1
Histone Deacetylase Inhibitors
1
GRN163L peptide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polycythemia
×
Phlebotomy
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled